Targeted interleukin-10 plasmid DNA therapy in the treatment of osteoarthritis: Toxicology and pain efficacy assessments
Journal Article
Overview
publication date
- November 1, 2020
has subject area
- Animal Diseases - Disease Models, Animal
- Animals
- Arthritis - Osteoarthritis
- Biological Factors - Interleukin-10
- Biological Therapy - Genetic Therapy
- Chronic Pain
- Dogs
- Genetic Engineering - Genetic Therapy
- Joint Diseases - Arthralgia
- Models, Animal - Disease Models, Animal
- Models, Biological - Disease Models, Animal
- Musculoskeletal Diseases - Osteoarthritis
- Nervous System Physiological Phenomena - Arthralgia
- Nervous System Physiological Phenomena - Pain
- Peptides - Interleukin-10
- Plasmids
- Proteins - Interleukin-10
- Psychological Phenomena - Arthralgia
- Psychological Phenomena - Pain
- Signs and Symptoms - Arthralgia
- Signs and Symptoms - Pain
has restriction
- closed
Date in CU Experts
- August 26, 2020 2:38 AM
Full Author List
- Watkins LR; Chavez RA; Landry R; Fry M; Green-Fulgham SM; Coulson JD; Collins SD; Glover DK; Rieger J; Forsayeth JR
author count
- 10
citation count
- 35
published in
- Brain, Behavior, and Immunity Journal
Other Profiles
International Standard Serial Number (ISSN)
- 0889-1591
Electronic International Standard Serial Number (EISSN)
- 1090-2139
Digital Object Identifier (DOI)
Additional Document Info
start page
- 155
end page
- 166
volume
- 90